Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jussi M Halleen

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Anticancer Research|June 25, 2003
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorptionJussi M Halleen
Expert Opinion on Drug Discovery|July 25, 2012
Models and screening assays for drug discovery in osteoporosisJukka P Rissanen, Jussi M Halleen
Cells|July 2, 2021
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone MetastasisTiina E Kähkönen, Jussi M Halleen, Jenni Bernoulli
Cancers|June 24, 2020
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug DevelopmentTiina E Kähkönen, Jussi M Halleen, Jenni Bernoulli
Calcified Tissue International|December 18, 2007
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy modelJukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Biochemical and Biophysical Research Communications|August 7, 2003
Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calciumHannele Ylipahkala, Jussi M Halleen, Helena Kaija, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2003
Potential function for the ROS-generating activity of TRACPJussi M Halleen, Seija R Räisänen, Sari L Alatalo, et al.
Frontiers in Immunology|July 21, 2023
Insights into immuno-oncology drug development landscape with focus on bone metastasisTiina E Kähkönen, Jussi M Halleen, Gary MacRitchie, et al.
Clinical Laboratory|November 3, 2006
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorptionJussi M Halleen, Sari L Tiitinen, Hannele Ylipahkala, et al.
Clinical Laboratory|September 5, 2009
Specificity and clinical performance of two commercial TRACP 5b immunoassaysHannele Ylipahkala, Katja M Fagerlund, Anthony J Janckila, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Anticancer Research|June 25, 2003
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorptionJussi M Halleen
Expert Opinion on Drug Discovery|July 25, 2012
Models and screening assays for drug discovery in osteoporosisJukka P Rissanen, Jussi M Halleen
Cells|July 2, 2021
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone MetastasisTiina E Kähkönen, Jussi M Halleen, Jenni Bernoulli
Cancers|June 24, 2020
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug DevelopmentTiina E Kähkönen, Jussi M Halleen, Jenni Bernoulli
Calcified Tissue International|December 18, 2007
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy modelJukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Biochemical and Biophysical Research Communications|August 7, 2003
Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calciumHannele Ylipahkala, Jussi M Halleen, Helena Kaija, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 31, 2003
Potential function for the ROS-generating activity of TRACPJussi M Halleen, Seija R Räisänen, Sari L Alatalo, et al.
Frontiers in Immunology|July 21, 2023
Insights into immuno-oncology drug development landscape with focus on bone metastasisTiina E Kähkönen, Jussi M Halleen, Gary MacRitchie, et al.
Clinical Laboratory|November 3, 2006
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorptionJussi M Halleen, Sari L Tiitinen, Hannele Ylipahkala, et al.
Clinical Laboratory|September 5, 2009
Specificity and clinical performance of two commercial TRACP 5b immunoassaysHannele Ylipahkala, Katja M Fagerlund, Anthony J Janckila, et al.
Pageof 4